日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Clinical outcomes of gastroenteropancreatic neuroendocrine neoplasms in Taiwan: A multicenter registry study-TCOG T1214 study.

台湾胃肠胰神经内分泌肿瘤的临床结果：一项多中心注册研究——TCOG T1214 研究

期刊:Cancer
影响因子:5.1
doi:10.1002/cncr.70019
Tsai Hui-Jen, Chen Ming-Huang, Wang Hsiu-Po, Hsiao Chin-Fu, Chen Yen-Yang, Chen Jen-Shi, Yang Mei-Due, Tzen Chin-Yuan, Shan Yan-Shen, Bai Li-Yaun, Chan De-Chuan, Chu Pei-Yi, Ho Ching-Liang, Yang Youngsen, Lin Johnson, Lin Hsuan-Yu, Chang Cheng-Shyong, Wang Chuan-Cheng, Hwang Tsann-Long, Chen Li-Tzong
免疫/内分泌
神经科学
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Systemic treatments in pancreatic cancer: Taiwan pancreas society recommendation

胰腺癌全身治疗：台湾胰腺学会建议

期刊:Biomedical Journal
影响因子:4.4
doi:10.1016/j.bj.2023.100696
Su, Yung-Yeh; Chiang, Nai-Jung; Chiu, Tai-Jan; Huang, Chien-Jui; Hsu, Shao-Jung; Lin, Hsin-Chen; Yang, Shih-Hung; Yang, Youngsen; Chou, Wen-Chi; Chen, Yen-Yang; Bai, Li-Yuan; Li, Chung-Pin; Chen, Jen-Shi
胰腺癌
肿瘤
肿瘤免疫
发表日期：2024
文献求助 收藏

Comparison of molecular responses and outcomes between BCR::ABL1 e14a2 and e13a2 transcripts in chronic myeloid leukemia

慢性粒细胞白血病中 BCR::ABL1 e14a2 和 e13a2 转录本的分子反应和预后比较

期刊:Cancer Science
影响因子:4.3
doi:10.1111/cas.15501
Su, Yi-Jiun; Kuo, Ming-Chung; Chen, Tsai-Yun; Wang, Ming-Chung; Yang, Youngsen; Ma, Ming-Chun; Lin, Tung-Liang; Lin, Tung-Huei; Chang, Hung; Teng, Chieh-Lin Jerry; Hsiao, Pei-Ching; Chen, Chih-Cheng; Wang, Po-Nan; Shih, Lee-Yung
ABL1
粒细胞
白血病
BCR
细胞生物学
发表日期：2022
文献求助 收藏

Afatinib alone and in combination with vinorelbine or paclitaxel, in patients with HER2-positive breast cancer who failed or progressed on prior trastuzumab and/or lapatinib (LUX-Breast 2): an open-label, multicenter, phase II trial

在既往接受曲妥珠单抗和/或拉帕替尼治疗失败或疾病进展的HER2阳性乳腺癌患者中，阿法替尼单药治疗以及联合长春瑞滨或紫杉醇治疗的疗效（LUX-Breast 2）：一项开放标签、多中心、II期临床试验

期刊:Breast Cancer Research and Treatment
影响因子:3
doi:10.1007/s10549-021-06449-4
Hickish, Tamas; Mehta, Ajay; Liu, Mei-Ching; Huang, Chiun-Sheng; Arora, Rajendra Singh; Chang, Yuan-Ching; Yang, Youngsen; Vladimirov, Vladimir; Jain, Minish; Tsang, Janice; Pemberton, Karine; Sadrolhefazi, Behbood; Jin, Xidong; Tseng, Ling-Ming
HER2
肿瘤
肿瘤免疫
乳腺癌
发表日期：2022
文献求助 收藏

A multi-national, randomised, open-label, parallel, phase III non-inferiority study comparing NK105 and paclitaxel in metastatic or recurrent breast cancer patients

一项多中心、随机、开放标签、平行组、III期非劣效性研究，比较NK105和紫杉醇在转移性或复发性乳腺癌患者中的疗效。

期刊:British Journal of Cancer
影响因子:6.8
doi:10.1038/s41416-019-0391-z
Fujiwara, Yasuhiro; Mukai, Hirofumi; Saeki, Toshiaki; Ro, Jungsil; Lin, Yung-Chang; Nagai, Shigenori E; Lee, Keun Seok; Watanabe, Junichiro; Ohtani, Shoichiro; Kim, Sung Bae; Kuroi, Katsumasa; Tsugawa, Koichiro; Tokuda, Yutaka; Iwata, Hiroji; Park, Yeon Hee; Yang, Youngsen; Nambu, Yoshihiro
NK1
肿瘤
肿瘤免疫
乳腺癌
发表日期：2019
文献求助 收藏